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Abstract
This unblinded preliminary case-control study was done to
demonstrate functional and structural changes in the
microcirculation of patients with primary fibromyalgia (FM). We
studied 10 women (54.0 ± 3.7 years of age) with FM diagnosed
in accordance with the classification criteria of the American
College of Rheumatology, and controls in three groups (n = 10
in each group) – age-matched women who were healthy or who
had rheumatoid arthritis or systemic scleroderma (SSc). All 40
subjects were tested within a 5-week period by the same
investigators, using two noninvasive methods, laser fluxmetry
and capillary microscopy. The FM patients were compared with
the healthy controls (negative controls) and with rheumatoid
arthritis patients and SSc patients (positive controls). FM
patients had fewer capillaries in the nail fold (P < 0.001) and
significantly more capillary dilatations (P < 0.05) and irregular
formations (P < 0.01) than the healthy controls. Interestingly, the
peripheral blood flow in FM patients was much less (P < 0.001)
than in healthy controls but did not differ from that of SSc
patients (P = 0.73). The data suggest that functional
disturbances of microcirculation are present in FM patients and
that morphological abnormalities may also influence their
microcirculation.
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Introduction
Vasospastic symptoms occur in about 30% of patients with
primary fibromyalgia (FM) [1]. These patients present with
Raynaud's phenomenon and intolerance to cold [2]. Frodin
and colleagues, using nailfold capillaroscopy in FM
patients, found slight morphological changes, such as
moderate enlargement of capillary loops and variations in
calibre [3]. Jeschonneck and colleagues showed
decreased microcirculatory blood flow above tender points
in FM patients [4]. About 60% to 90% of systemic sclero-
derma (SSc) patients have Raynaud's phenomenon [5]. In
patients with SSc other workers, using videomicroscopy
with sodium fluorescein, have found typical changes of the
nailfold capillaries, characterised by reduced capillary den-
sity, giant capillaries, avascular fields, microhaemorrhages,
and disturbance of diffusion [6]. Furthermore, in rheuma-
toid arthritis (RA), peripheral malperfusion and vasculitis
occur [7], resulting in skin ulcers, neuropathy, necrosis, or
gangrene.
Our aim in this preliminary study was to investigate capillary
abnormalities and blood flow by two independent objective
methods, capillary microscopy and laser Doppler fluxmetry,
to obtain evidence of disturbed microcirculation in FM
patients.
Materials and methods
The study group consisted of 10 women (54.0 ± 3.7 years
of age) from the Outpatient Department in the Department
of Rheumatology, University Hospital, Zurich, with primary
FM classified in accordance with the criteria of the Ameri-
can College of Rheumatology [8]. The controls were three
groups (n = 10 in each group) of age-matched women who
FM = primary fibromyalgia; RA = rheumatoid arthritis; SSc = systemic scleroderma.Arthritis Research & Therapy    Vol 7 No 2    Morf et al.
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Table 1
Characteristics of patients and controls studied.
Group, and subject no. Risk factor Raynaud's phenomenon Medsger scorea
Patients with fibromyalgia
1O b e s i t y -
2- -
3- -
4- X
5- X
6O b e s i t y -
7- -
8- -
9- -
10 - -
Controls with systemic scleroderma (SSc)
1- X4
2- X3
3- X2
4- -1
5- X2
6O b e s i t y X2
7E x - s m o k e r X1
8E x - s m o k e r X3
9- X1
10 - X 3
Controls with rheumatoid arthritis
1O b e s i t y -
2 Hypertension -
3- -
4- -
5- -
6O b e s i t y -
7 Hypertension -
8- -
9- -
10 - -
Healthy controls
1O b e s i t y -
2E x - s m o k e r -Available online http://arthritis-research.com/content/7/2/R209
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were healthy (negative controls) or who had symptomatic
RA or SSc (positive controls). The subjects were studied
using laser Doppler fluxmetry and capillary microscopy.
None of the subjects had vasculitis. The RA patients did not
have Raynaud's phenomenon and only 2 of the 10 had
hypertension as a possible risk factor for small-vessel dis-
ease. Although the SSc patients did not have vasculitis, all
except one presented with a typical Raynaud's syndrome,
with a mean Medsger score [9] of 2.2 ± 1.03. This score
describes how advanced the disease is (Table 1); a low
scores (0 or 1) indicates no or mild SSc, and a high score
(4) indicates the end stage. Smokers and patients treated
with nitrate or Ca2+-channel blockers were excluded from
the study. The study was approved by the local ethical com-
mittee of the University Hospital, Zurich.
Capillary microscopy
The morphology of nailfold capillaries has been studied by
intravital capillaroscopy (Leica, Glattbrugg, Switzerland) at
a magnification of 50× [10]. The room temperature was
maintained between 22°C and 24°C. Patients were exam-
ined in a sitting position after a resting time of at least 20
minutes. The capillaries were evaluated in accordance with
the criteria of the German Association of Angiology [11].
The following changes were analysed: density of capillaries
3- -
4- -
5- -
6E x - s m o k e r -
7O b e s i t y -
8- -
9- -
10 - -
aAssigned to SSc patients only; indicates severity of the disease, from 0 to 4 (none to end stage) [9]. -, Not present; X, present.
Table 1 (Continued)
Characteristics of patients and controls studied.
Figure 1
Curves depicting the four types of reactive hyperaemia measured by  laser Doppler fluxmetry after occlusion of blood flow with a blood-pres- sure cuff for 3 minutes (occlusion marked by vertical dashed lines) Curves depicting the four types of reactive hyperaemia measured by 
laser Doppler fluxmetry after occlusion of blood flow with a blood-pres-
sure cuff for 3 minutes (occlusion marked by vertical dashed lines). 
(Reproduced from reference [13] with permission.)
Figure 2
Example of capillary microscopy of the nail fold of a 44-year-old FM  patient Example of capillary microscopy of the nail fold of a 44-year-old FM 
patient. The number of capillaries per millimetre (6) is reduced and cap-
illary dilatations and irregular formations of the capillaries are present.Arthritis Research & Therapy    Vol 7 No 2    Morf et al.
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(normal 7–16 capillaries per millimetre), microhaemor-
rhages, dilatation of capillaries, giant capillaries, and 'irreg-
ular formations' (that is, instances where capillaries were
arranged in clusters with gaps in between). A dilatation was
considered to be present when the arteriolar limb of the
capillary loop was thicker than 50 µm and the venous limb
was thicker than 20 µm, and giant capillaries were defined
as those having an apex diameter of over 50 µm [11].
Laser Doppler fluxmetry
Skin blood flow was measured in supine subjects at the lat-
eral epicondyle (typical FM tender point [8]), in fingertips II
and III (that is, of the forefinger and middle finger) and in the
lower arm (control point) using the laser Doppler technique
(PeriFlux PF3; Perimed, Järfälla, Sweden), as described
elsewhere [12]. A blood-pressure cuff was positioned on
the upper arm and standard laser Doppler probes for skin
blood flow measurements were attached to the epicondyle,
fingertips II and III, and the lower arm. The resting flow was
recorded 5 minutes before the cuff pressure was inflated to
a suprasystolic level for 3 minutes. After release of the cuff
pressure, reactive hyperaemia was recorded at the four
defined areas. The time to peak flow and type of peak were
evaluated in each group [13]. Peak flow corresponds to the
highest flow value after release of the cuff.
Four types of reactive hyperaemia were identified [13] (Fig.
1). In type A, the first peak is within 23 seconds after cuff
release and is followed by a second, smaller, wave. In type
B, the amplitude of the second wave is greater than that of
the first; the first peak is characterised by a fast dilatation of
the myogen-activated arterioles and small arteries with a
concomitant increase of the vessel tonus. Both types A and
B are biphasic and are classified as 'normal', because so far
they have been predominantly found in healthy subjects
[13]. They also show the same characteristics in therapy
and there is so far no proof that one type predisposes to a
certain illness. Type C is monophasic; the fast initial com-
ponent of the muscular reaction is absent. In type D, pos-
tocclusive reactive hyperaemia is missing. Types C and D
are pathological reactions.
The Mann–Whitney U test was used for statistical compar-
ison of the groups. P values < 0.05 were considered to be
statistically significant. Means ± standard deviations are
given.
Results
Capillary microscopy
The density of capillaries per millimetre in FM patients (9.92
± 0.19) was significantly lower than in controls (11.31 ±
0.34) (P < 0.001) but still within the normal range. Four or
more capillary dilatations were detected in 2 of the 10 FM
patients (Fig. 2), and one to three dilatations per nail fold
Figure 3
Number of capillaries (mean ± standard deviation) per millimetre in the  nail fold as seen on capillary microscopy Number of capillaries (mean ± standard deviation) per millimetre in the 
nail fold as seen on capillary microscopy. *P < 0.05 in comparison with 
healthy controls (Co); **P < 0.01 in comparison with Co and with pri-
mary fibromyalgia (FM) or rheumatoid arthritis (RA) patients; ***P < 
0.001 in comparison with Co.
Figure 4
Time (s) (mean ± standard deviation) to peak capillary flow after occlusion of blood flow with a blood-pressure cuff on the upper arm for 3 minutes Time (s) (mean ± standard deviation) to peak capillary flow after occlusion of blood flow with a blood-pressure cuff on the upper arm for 3 minutes. 
Measurements were made using laser Doppler fluxmetry. In primary fibromyalgia (FM) and systemic scleroderma (SSc) patients, the time to peak in 
the lateral epicondyle was longer than in healthy controls (Co). In SSc patients, the times to peak in the second and third fingertips were longer than 
those in FM patients and healthy controls. *P < 0.001 in comparison with Co; °P < 0.05 in comparison with Co and with FM patients; +P < 0.05 in 
comparison with Co and with FM or rheumatoid arthritis (RA) patients.Available online http://arthritis-research.com/content/7/2/R209
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were detected in 6 of the10 FM patients. No microhaemor-
rhages, giant capillaries, or avascular fields were detected
in FM patients.
The number of capillaries in patients with SSc (6.21 ±
1.03) was significantly lower than in healthy controls (Fig.
3) and significantly more microhaemorrhages were found in
SSc patients (8 of 10) than in controls or in FM or RA
patients (P < 0.01). Giant capillaries were detected only in
SSc patients.
Laser Doppler fluxmetry
The time to peak blood flow at the lateral epicondyle was
significantly longer in FM (7 ± 0.5 s) and SSc (7 ± 0.91 s)
patients than in healthy controls (4 ± 0.34 s) (Fig. 4). In
SSc patients, the time to the peak in the second finger (7.5
± 1.22 s) was significantly longer than in FM patients (5 ±
0.27 s) and healthy controls (4.5 ± 0.58 s) and also in the
third finger (7.5 ± 0.67 s, 5 ± 0.3 s, and 4.5 ± 0.17 s,
respectively) (Fig. 4). In RA patients, the time to the peak in
the second finger (7 ± 1.15 s) was significantly longer than
in FM patients (5 ± 0.27 s) and healthy controls (4.5 ± 0.58
s). In the lateral epicondyle, both FM and SSc patients had
longer times to peak than the healthy controls (Fig. 4).
All of the FM patients showed a type-B hyperaemic
response in the lower-arm and epicondyle measurements
(Fig. 5). The monophasic, type-C response was seen at the
Figure 5
Histograms showing types of peak flow as measured using laser Doppler fluxmetry [13] Histograms showing types of peak flow as measured using laser Doppler fluxmetry [13]. (a) In the lower arm and (b) at the lateral epicondyle [13] of 
patients with systemic scleroderma (SSc), rheumatoid arthritis (RA), or primary fibromyalgia (FM) and in healthy controls (Co). *P < 0.05, **P < 0.01, 
in comparison with Co.Arthritis Research & Therapy    Vol 7 No 2    Morf et al.
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lateral epicondyle in 6 of 10 RA patients and 6 of 10 SSc
patients. One patient with SSc and one with RA showed no
postocclusive reaction (type D) either in the lower arm or at
the lateral epicondyle.
In measurements made in the fingers, FM patients showed
the postocclusive, type-B response in fingers II and III (Fig.
6a,6b), except for a type-A response in finger II in one
patient. This was significantly different from the response in
healthy controls (P  < 0.01). The monophasic, type-C
response was found in some patients with SSc and RA. In
one patient with SSc, a type-D response was observed in
all four fingers.
Discussion
Patients with FM and SSc present functional as well as
morphological changes in microcirculation, but the dis-
eases are distinguishable by the severity of morphological
pathologies of capillaries in SSc. Specific capillary abnor-
malities are present in patients with SSc and have a high
predictive value [5]. These changes and the irregular forma-
tions in SSc may be due to microinfarcts [14]. Our results
show that the density of capillaries in patients with FM is
still normal but lower than in healthy controls. In an earlier
study, however, it was reported that the number of
capillaries is decreased [15]. Morphological abnormalities
and vascular malfunction (spasms) therefore have to be
discussed as possible reasons for this decreased number
of capillaries. In our study, the main finding is a longer time
to peak flow (reactive hyperaemia) after occlusion in FM
patients than in the healthy controls. An earlier study [13]
showed that 80% of healthy persons have a biphasic type
of reactive hyperaemia, such as type A or B (see Fig. 1).
Apart from one type-A response in the second fingertip, all
of the patients with FM whom we studied were recorded as
having a type-B response. This type of response is classi-
Figure 6
Histograms showing types of peak flow as measured using laser Doppler fluxmetry [13] Histograms showing types of peak flow as measured using laser Doppler fluxmetry [13]. In the (a) second and (b) third fingertips of patients with 
systemic scleroderma (SSc), rheumatoid arthritis (RA), or primary fibromyalgia (FM) and in healthy controls (Co). °P < 0.05 in comparison with Co; 
§P < 0.05 in comparison with Co and FM; *P < 0.05 in comparison with Co, FM and RA; **P < 0.01 in comparison with Co.Available online http://arthritis-research.com/content/7/2/R209
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fied as 'normal', but it lacks the first, fast, myogen-activated
peak. The explanation may be that FM patients have a
reduced primary muscular vessel reaction whereas – and
this is important – the second wave is normal.
The small number of patients in this preliminary study may
be a limitation in that we may have coincidentally recorded
10 FM patients with a type-B response to occlusion of the
blood flow. Further studies with more patients are needed
to confirm this finding.
The missing fast component of reactive hyperaemia in our
FM population is presumably due to a higher sympathetic
tonus, resulting in increased vasoconstriction; this
increased vasoconstriction would explain both the signifi-
cantly increased time to peak, especially at the lateral epi-
condyle – which is a tender point in FM – and the reduced
density of vessels. Earlier workers [4] advanced the idea
that psychological and physical situations of stress might
have an impact on this system. Local ischaemia, which may
result from these proposed mechanisms in more advanced
stages of the disease, could be a possible explanation for
Raynaud's phenomenon in a fraction of FM patients. This
local ischaemia results in an influence on spinal and
supraspinal structures with sympathetic and motor
efferences.
SSc patients showed also a prolonged time to peak flow at
all points studied. It is well known that endothelial changes
are present in SSc [14].
Both morphological and symptomatic disturbances in
microcirculation can occur in FM but occur most often in
SSc [16]. Functional changes have already been observed
in FM, SSc, and RA [7,17]. However, the changes in FM
support the hypothesis of increased sympathetic activity,
and hence a functional hyperexcitability of the sympathetic
nervous system [4].
Conclusion
We have shown that functional changes of the microcircu-
lation are present in patients with FM and this finding may
be important for new treatment options in FM. A possible
therapeutic strategy could be selective suppression of the
sympathetic tone or the undertaking of symptomatic meas-
ures to activate the microcirculation, such as active and
passive physical methods.
Because the unblinded design was a weakness of this pre-
liminary study, blinded studies with more patients are
needed to confirm our findings.
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